GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » 3-Year Revenue Growth Rate

NextCell Pharma AB (OSTO:NXTCL) 3-Year Revenue Growth Rate : 29.00% (As of Feb. 2024)


View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB 3-Year Revenue Growth Rate?

NextCell Pharma AB's Revenue per Share for the three months ended in Feb. 2024 was kr0.07.

During the past 12 months, NextCell Pharma AB's average Revenue per Share Growth Rate was 77.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 29.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 31.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 9 years, the highest 3-Year average Revenue per Share Growth Rate of NextCell Pharma AB was 300.00% per year. The lowest was 5.60% per year. And the median was 27.90% per year.


Competitive Comparison of NextCell Pharma AB's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, NextCell Pharma AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NextCell Pharma AB's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NextCell Pharma AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where NextCell Pharma AB's 3-Year Revenue Growth Rate falls into.



NextCell Pharma AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


NextCell Pharma AB  (OSTO:NXTCL) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


NextCell Pharma AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of NextCell Pharma AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


NextCell Pharma AB (OSTO:NXTCL) Business Description

Traded in Other Exchanges
Address
Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines